Imbalanced matrix metalloproteinases in cardiovascular complications of end-stage kidney disease: a potential pharmacological target
about
Association of angiotensinogen M235T gene polymorphism with end-stage renal disease risk: a meta-analysis.Matrix Metalloproteinase (MMP)-9 Levels in Children on Hemodialysis: Association with MMP-9 C-1562T Gene Polymorphism and Vitamin D Levels.Lack of association of angiotensin II type 1 receptor A1166C gene polymorphism with the risk of end-stage renal disease.Association of dialysate calcium concentration with fetuin A level and carotid intima-media thickness in peritoneal dialysis patients.Nitric oxide attenuates matrix metalloproteinase-9 production by endothelial cells independent of cGMP- or NFκB-mediated mechanisms.A meta-analysis of the association between angiotensin-converting enzyme insertion/deletion gene polymorphism and end-stage renal disease risk in IgA nephropathy patients.
P2860
Imbalanced matrix metalloproteinases in cardiovascular complications of end-stage kidney disease: a potential pharmacological target
description
2012 nî lūn-bûn
@nan
2012 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Imbalanced matrix metalloprote ...... tential pharmacological target
@ast
Imbalanced matrix metalloprote ...... tential pharmacological target
@en
Imbalanced matrix metalloprote ...... tential pharmacological target
@nl
type
label
Imbalanced matrix metalloprote ...... tential pharmacological target
@ast
Imbalanced matrix metalloprote ...... tential pharmacological target
@en
Imbalanced matrix metalloprote ...... tential pharmacological target
@nl
prefLabel
Imbalanced matrix metalloprote ...... tential pharmacological target
@ast
Imbalanced matrix metalloprote ...... tential pharmacological target
@en
Imbalanced matrix metalloprote ...... tential pharmacological target
@nl
P2860
P1476
Imbalanced matrix metalloprote ...... tential pharmacological target
@en
P2093
Bernardo P Marson
Jose E Tanus-Santos
P2860
P304
P356
10.1111/J.1742-7843.2012.00863.X
P407
P577
2012-03-02T00:00:00Z